Skip to main content
. 2023 May 24;5(6):318–328. doi: 10.1002/acr2.11550

Figure 1.

Figure 1

Study design. The index date for patients with no OCS pharmacy claims was imputed based on the distribution of time between the first claim with a systemic lupus erythematosus diagnosis in the continuous eligibility period and the index date in the OCS‐initiator cohort. OCS, oral corticosteroid.